CASE Statement: 30 Years in, Hospitals Continue to Exploit 340B.
November 7, 2022 The 340B program, a flawed plan that allows hospitals to steal savings meant for low-income patients,...
November 7, 2022 The 340B program, a flawed plan that allows hospitals to steal savings meant for low-income patients,...
June 21, 2021 This past year has been a difficult one for American patients. Due to COVID-19 and the financial...
December 19, 2019 Surprise medical billing creates undue financial hardships for patients and their families at a time when all...
August 16, 2019 Last month, The Centers for Medicare and Medicaid Services released a new proposal which will increase price...
As consumers, we all understand the need to shop around. When buying gas, a TV or even a car we...
On November 6, voters consistently identified healthcare as the number one issue they were concerned about. Put a different way:...
This week, multiple associations and hospital groups refiled a lawsuit to reverse changes made to the 340B program. We’ve written...
For most people, a trip to the hospital is frightening. Even for routine treatments, hospitalizations can be confusing and anxiety...
This week President Trump will unveil his plan to help bring down the cost of prescription drugs, helping fulfill his...
The Health Care Price Index rose by 2.2 percent from March 2017 to March 2018, the largest price increase since...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/